SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 27, 16:30
706.90
0.65 (0.09%)
VOLUME 68,206
LIVE
NSE
Jan 27, 16:30
707.95
1.35 (0.19%)
VOLUME 656,889
News on Ranbaxy Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Six in Sixty: Stocks you should keep on your radar 

2.59 pm | 27 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on – Maruti, Ranbaxy, BEL, Max India, HDIL, Tata Motors, Asian paints, Cipla, HDFC b...

'Ranbaxy's Nexium generic loss may up Cipla's EPS 3-5%' 

2.19 pm | 27 Jan 2015 |  Source: CNBC-TV18

The US FDA’s decision to revoke the 180-day exclusivity cover extended to Indian firm Ranbaxy to sell a generic version of the world’s second-larg...

Ranbaxy forfeits 180 days exclusivity for stomach drugs

1.17 pm | 27 Jan 2015 |  Source: PTI

Drug major Ranbaxy today said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity f...

Here are top 10 stocks to focus on January 27 

8.54 am | 27 Jan 2015 |  Source: CNBC-TV18

Here are top 10 stocks to focus on January 27 - HDFC, Hindustan Unilever (HUL), Larsen and Toubro (L&T), Bharat Heavy Electricals (BHEL), Ultratech Ce...

Stocks in news: TVS Motor, SBI, Ranbaxy, Hindalco, Maruti

8.34 am | 27 Jan 2015 |  Source: CNBC-TV18

Hindalco Industries | TVS Motor | SBI | Ranbaxy Labs | Maruti Suzuki | Idea Cellular | United Spirits | City Union Bank | Tata Coffee | Persistent Sys...

Sun Pharma chief expects Ranbaxy deal to be done by mid-Feb

4.54 pm | 25 Jan 2015 |  Source: PTI

Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating th...

Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma 

11.13 am | 23 Jan 2015 |  Source: CNBC-TV18

VK Sharma of HDFC Securities recommends buying Lupin 1500 call and Ranbaxy Labs 700 Call....

Six in Sixty: Stocks you should keep on your radar 

2.49 pm | 22 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Suzlon, Sun Pharma, Ranbaxy, HUL, ITC, Zee Entertainment, Cairn India, Tata Motor...

Patent denied on Gilead's Hepatitis C drug Sovaldi

8.49 pm | 15 Jan 2015 |  Source: CNBC-TV18

The order is a big set back for Gilead. The patent denial comes close to a decade after Gilead first filed its patent application and was close to a l...

Merck Millipore bets big on India amid regulatory concerns 

9.51 pm | 08 Jan 2015 |  Source: CNBC-TV18

Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportu...

Prefer pharma space, says Dilip Bhat 

11.26 am | 31 Dec 2014 |  Source: CNBC-TV18

According to Dilip Bhat of Prabhudas Lilladher, one may bet on pharmaceutical space....

2015 will be good, but not as good as '14; like Maruti:Bhat 

9.46 am | 31 Dec 2014 |  Source: CNBC-TV18

Dilip Bhat of Prabhudas Lilladher says the possibility of excise duty concession being withdrawn from the auto sector is a known factor and it is unli...

2014: Blockbuster year for Sun Pharma's Dilip Shanghvi 

7.37 pm | 30 Dec 2014 |  Source: CNBC-TV18

2014 was a glitzy year for this man. With a net worth of USD 18 billion, 59-year-old Shanghvi became the second richest man in India, out-ranking Laks...

Crystal ball gazing: Here's what to buy in 2015  

3.37 pm | 30 Dec 2014 |  Source: CNBC-TV18

2014 was a great year for stock picking in the Indian market with the Nifty gaining 30 percent. As market heads into 2015, what are experts recommendi...

Sell UPL, buy Ranbaxy: Meghana Malkan 

3.16 pm | 29 Dec 2014 |  Source: CNBC-TV18

Meghana V Malkan of malkansview.com advises buying Ranbaxy with target of Rs 648....

Sun's margins may reduce to 30-32% post merger: Surajit Pal 

12.36 pm | 29 Dec 2014 |  Source: CNBC-TV18

As 2014 comes to an end, Surajit Pal of Prabhudas Lilladher shares his outlook on the year that was and the possible trends for 2015....

Prefer pharma, underweight on IT: Dipan Mehta 

5.21 pm | 26 Dec 2014 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharma stocks....

'Mkt to see resistance at 8300, accumulate select stocks' 

4.52 pm | 19 Dec 2014 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com does not believe that the market is going to once again get into a big upward rally. ...

Angel Broking neutral on Ranbaxy Laboratories

12.25 pm | 18 Nov 2014 |  Source: Moneycontrol.com

Angel Broking has maintained a neutral rating on Ranbaxy Laboratories, in its November 3, 2014 research report....

Merger with Ranbaxy might get delayed: Sun CFO Baldota 

11.59 am | 14 Nov 2014 |  Source: CNBC-TV18

The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally....

1 2 3 4 5 6
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.